Table 1 Baseline characteristics
Variable | N = 51 |
|---|---|
Age, years (IQR) | 63 (55–70) |
Gender (female/male), n (%) | 29 (57)/22 (43) |
BMI | 25.6 (16–42.6) |
ASA score (%) | |
2003ASA I | 3 (6) |
ASA II | 35 (69) |
ASA III | 13 (25) |
Synchronous/metachronous metastases, n (%) | 21 (41)/30 (59) |
Liver involvment, unilobar/bilobar, n (%) | 38 (74)/13 (26) |
Disease free interval, months (IQR) | 16 (0–51) |
Extrahepatic disease, n (%) | 16 (31) |